Delivery Order SPE2DR25D3501-SPE2DR26FM2KF
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,684.75 to AmerisourceBergen Drug Corp for the supply of Oseltamivir Phosphate 75 mg capsules (100-count units) on January 6, 2026, with completion expected by January 7, 2026. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the awardee's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major...
- The Defense Logistics Agency awarded a $3,133.60 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Oseltamivir Phosphate 75 mg capsules (unit dose, 10-count packaging) on January 6, 2026, with completion targeted for January 7, 2026. The award was made without set-aside restrictions through open competition. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location in Conshohocken, PA...
- The Defense Logistics Agency awarded a $5,694.32 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Oseltamivir Phosphate 75 mg capsules in unit dose packaging (10-count) on December 2, 2025, with completion due by December 3, 2025. This competitive award, which received no set-aside designation, will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $4,278.86 to AmerisourceBergen Drug Corp for Oseltamivir Phosphate 75 mg capsules in unit dose packaging on January 7, 2026, with completion expected by January 8, 2026. The contract employs firm fixed pricing and carries no set-aside designation, indicating competitive award. Performance will be executed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $1,388.84 to supply Oseltamivir Phosphate 75 mg capsules in unit dose packages of 10 units. The order was competitively awarded with no set-aside designation and carries a firm fixed price structure with an ultimate completion date of December 19, 2025. AmerisourceBergen will perform this work from its corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a $4,994.40 firm fixed-price delivery order to AmerisourceBergen Drug Corp on January 7, 2026, for the supply of Oseltamivir Phosphate 75 mg capsules in unit dose packaging (10s). This is a non-set-aside competitive award with an ultimate completion date of January 8, 2026, and performance location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor serving federal...
- The Defense Logistics Agency awarded a delivery order valued at $2,545.85 to AmerisourceBergen Drug Corp for Oseltamivir Phosphate 75 mg capsules in unit dose packaging of 10s. This order, issued on November 20, 2025, with completion targeted for November 21, 2025, represents a firm fixed price delivery against AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The contract was competitively awarded without set-aside designations, reflecting open...
- The Defense Logistics Agency awarded a delivery order valued at $2,031.84 to AmerisourceBergen Drug Corp for the supply of Oseltamivir Phosphate 75 mg capsules in unit dose packages of 10 units. This firm fixed-price, non-set-aside contract was awarded on January 13, 2026, with an ultimate completion date of January 14, 2026, and will be performed at the awardee's location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major...
- The Defense Logistics Agency awarded a $4,553.92 firm fixed price delivery order to AmerisourceBergen Drug Corp for Oseltamivir Phosphate 75 mg capsules in unit dose packages of 10. The contract was competitively awarded without a set-aside designation and carries an ultimate completion date of September 4, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $1,690.92 to AmerisourceBergen Drug Corp for Oseltamivir Phosphate 75 mg capsules (Unit Dose, 10-count) on January 7, 2026, with an ultimate completion date of January 8, 2026. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a task order under AmerisourceBergen's parent company...
- SPE2DR25D3501Indefinite Delivery Contract
- SPE2DR25D3501-SPE2DR26FM2KFDelivery Order
The Defense Logistics Agency awarded a $1,243.60 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Oseltamivir Phosphate 75 mg capsules in unit dose packaging on January 14, 2026, with completion targeted for January 15, 2026. The award, issued without set-aside restrictions, represents a competitively awarded task order for pharmaceutical supply to support federal medical needs. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is headquartered in Conshohocken, Pennsylvania and serves as a critical vendor in the federal pharmaceutical supply chain, particularly for military and veteran healthcare systems. This delivery order was issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. This comprehensive IDC vehicle enables the contractor to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs globally, including medications, vaccines, and medical devices across multiple therapeutic domains. The structure allows the company to serve the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems through flexible procurement mechanisms typical of DLA's pharmaceutical prime vendor approach.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 1/13/26 |